Journal of Physiology and Biochemistry

, Volume 70, Issue 1, pp 73–79 | Cite as

Effect of melatonin supplementation and cross-fostering on renal glutathione system and development of hypertension in spontaneously hypertensive rats

  • Lee Siew-Keah
  • Arunkumar Sundaram
  • K. N. S. SirajudeenEmail author
  • Rahimah Zakaria
  • H. J. Singh
Original Paper


Antenatal and postnatal environments are hypothesised to influence the development of hypertension. This study investigates the synergistic effect of cross-fostering and melatonin supplementation on the development of hypertension and renal glutathione system in spontaneously hypertensive rats (SHR). In one experiment, 1-day-old male SHR pups were fostered to either SHR (shr-SHR) or Wistar-Kyoto rats, (shr-WKY). In a concurrent experiment, SHR dams were given melatonin in drinking water (10 mg/kg body weight) from day 1 of pregnancy. Immediately following delivery, 1-day-old male pups were fostered either to SHR (Mel-shr-SHR) or WKY (Mel-shr-WKY) dams receiving melatonin supplementation until weaning on day 21. Upon weaning, melatonin supplementation was continued to these pups until the age of 16 weeks. Systolic blood pressures (SBP) were recorded at the age of 4, 6, 8, 12 and 16 weeks. Renal antioxidant activities were measured. Mean SBP of shr-WKY, Mel-shr-SHR and Mel-shr-WKY was significantly lower than that in shr-SHR until the age of 8 weeks. At 12 and 16 weeks of age, mean SBP of Mel-shr-WKY was lower than those in non-treated shr-SHR and shr-WKY pups but was not significantly different from that in Mel-shr-SHR. Renal glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities were significantly higher in Mel-shr-SHR and Mel-shr-WKY at 16 weeks of age. It appears that combination of cross-fostering and melatonin supplementation exerts no synergistic effect on delaying the rise in blood pressure in SHR. The elevated GPx and GST activities are likely to be due to the effect of melatonin supplementation.


Cross-fostering Melatonin Maternal environment Glutathione system SHR 



This study was supported by the Research University Grant Scheme (RU 1001/PPSP/811018) provided by Universiti Sains Malaysia. The first author was sponsored by Universiti Sains Malaysia Research University Fellowship and the second author was sponsored by the Ministry of Science, Technology and Innovation Malaysia.

Conflicts of interest

No conflicts of interest, financial or otherwise are declared by the author(s).


  1. 1.
    Chaves FJ, Mansego ML, Blesa S, Gonzalez-Albert V, Jimenez J, Tormos MC, Espinosa O, Giner V, Iradi A, Saez G, Redon J (2007) Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens 20:62–69PubMedCrossRefGoogle Scholar
  2. 2.
    Chrissobolis S, Didion SP, Kinzenbaw DA, Schrader LI, Dayal S, Lentz SR, Faraci FM (2008) Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension 51:872–877PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Cierpial MA, McCarty R (1987) Hypertension in SHR rats: contribution of maternal environment. Am J Physiol 253:H980–H984PubMedGoogle Scholar
  4. 4.
    Delles C, Padmanabhan S, Lee WK, Miller WH, McBride MW, McClure JD, Brain NJ, Wallace C, Marcano AC, Schmieder RE, Brown MJ, Caulfield MJ, Munroe PB, Farrall M, Webster J, Connell JM, Dominiczak AF (2008) Glutathione S-transferase variants and hypertension. J Hypertens 26:1343–1352PubMedCrossRefGoogle Scholar
  5. 5.
    Di Nicolantonio R, Koutsis K, Westcott KT, Wlodek ME (2006) Relative contribution of the prenatal versus postnatal period on development of hypertension and growth rate of the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 33:9–16PubMedCrossRefGoogle Scholar
  6. 6.
    Dincer Y, Sekercioglu N, Pekpak M, Gunes KN, Akcay T (2008) Assessment of DNA oxidation and antioxidant activity in hypertensive patients with chronic kidney disease. Ren Fail 30:1006–1011PubMedCrossRefGoogle Scholar
  7. 7.
    Forgione MA, Weiss N, Heydrick S, Cap A, Klings ES, Bierl C, Eberhardt RT, Farber HW, Loscalzo J (2002) Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 282:H1255–H1261PubMedGoogle Scholar
  8. 8.
    Gouldsborough I, Black V, Johnson IT, Ashton N (1998) Maternal nursing behaviour and the delivery of milk to the neonatal spontaneously hypertensive rat. Acta Physiol Scand 162:107–114PubMedCrossRefGoogle Scholar
  9. 9.
    Khanna HD, Sinha MK, Khanna S, Tandon R (2008) Oxidative stress in hypertension: association with antihypertensive treatment. Indian J Physiol Pharmacol 52:283–287PubMedGoogle Scholar
  10. 10.
    Koenig JS, Fischer M, Bulant E, Tiran B, Elmadfa I, Druml W (1997) Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr 109:13–19PubMedGoogle Scholar
  11. 11.
    Koh-Tan HH, Graham D, Hamilton CA, Nicoll G, Fields L, McBride MW, Young B, Dominiczak AF (2009) Renal and vascular glutathione S-transferase mu is not affected by pharmacological intervention to reduce systolic blood pressure. J Hypertens 27:1575–1584PubMedCrossRefGoogle Scholar
  12. 12.
    Kotler M, Rodriguez C, Sainz RM, Antolin I, Menendez-Pelaez A (1998) Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 24:83–89PubMedCrossRefGoogle Scholar
  13. 13.
    Lee SK, Arunkumar S, Sirajudeen KN, Singh HJ (2010) Glutathione system in young spontaneously hypertensive rats. J Physiol Biochem 66:321–327PubMedCrossRefGoogle Scholar
  14. 14.
    Lee SK, Sirajudeen K, Sundaram A, Zakaria R, Singh H (2011) Effect of cross-fostering on renal anti-oxidant/oxidant status and development of hypertension in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 38:854–859PubMedCrossRefGoogle Scholar
  15. 15.
    Lee SK, Sirajudeen KN, Sundaram A, Zakaria R, Singh HJ (2011) Effects of antenatal, postpartum and post-weaning melatonin supplementation on blood pressure and renal antioxidant enzyme activities in spontaneously hypertensive rats. J Physiol Biochem 67:249–257PubMedCrossRefGoogle Scholar
  16. 16.
    Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB (2007) Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 115:2178–2187PubMedCrossRefGoogle Scholar
  17. 17.
    McCarty R, Tong H (1995) Development of hypertension in spontaneously hypertensive rats: role of milk electrolytes. Clin Exp Pharmacol Physiol Suppl 22:S215–S217PubMedCrossRefGoogle Scholar
  18. 18.
    Nava M, Quiroz Y, Vaziri N, Rodriguez-Iturbe B (2003) Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 284:F447–F454PubMedCrossRefGoogle Scholar
  19. 19.
    Nuyt AM, Alexander BT (2009) Developmental programming and hypertension. Curr Opin Nephrol Hypertens 18:144–152PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Ohta Y, Kongo M, Kishikawa T (2001) Effect of melatonin on changes in hepatic antioxidant enzyme activities in rats treated with alpha-naphthylisothiocyanate. J Pineal Res 31:370–377PubMedCrossRefGoogle Scholar
  21. 21.
    Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND (2003) Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41:341–346PubMedCrossRefGoogle Scholar
  22. 22.
    Vaziri ND, Wang XQ, Oveisi F, Rad B (2000) Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36:142–146PubMedCrossRefGoogle Scholar
  23. 23.
    Wilcox CS (2005) Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289:R913–R935PubMedCrossRefGoogle Scholar
  24. 24.
    Zhan CD, Sindhu RK, Vaziri ND (2004) Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation. Kidney Int 65:219–227PubMedCrossRefGoogle Scholar
  25. 25.
    Zicha J, Kunes J (1999) Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev 79:1227–1282PubMedGoogle Scholar
  26. 26.
    Zima T, Stipek S, Crkovska J, Nemecek K, Platenik J, Bartova V, Tesar V (1996) Antioxidant enzymes—superoxide dismutase and glutathione peroxidase—in haemodialyzed patients. Blood Purif 14:257–261PubMedCrossRefGoogle Scholar

Copyright information

© University of Navarra 2013

Authors and Affiliations

  • Lee Siew-Keah
    • 1
    • 4
  • Arunkumar Sundaram
    • 1
  • K. N. S. Sirajudeen
    • 2
    Email author
  • Rahimah Zakaria
    • 1
  • H. J. Singh
    • 3
  1. 1.Department of Physiology, School of Medical SciencesUniversiti Sains MalaysiaKubang KerianMalaysia
  2. 2.Department of Chemical Pathology, School of Medical SciencesUniversiti Sains MalaysiaKubang KerianMalaysia
  3. 3.Faculty of MedicineUniversiti Teknologi MARAShah AlamMalaysia
  4. 4.Faculty of Pharmaceutical SciencesUCSI UniversityKuala LumpurMalaysia

Personalised recommendations